Skip to content
sellWeak cluster of 210b5-1 plan

Wood Larry L sold $1.6M of EW

Global President TAVR & Surg at Edwards Lifesciences Corp. 25,000 shares at an average of $65.91, traded Nov 5, 2024, filed Nov 5, 2024.

Warning score
38
Value
$1.6M
25,000 shares
Holdings after
198,526
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

The components behind this score (role, size, price context, cluster, track record, modifiers) are shown to Pro users. Start with Pro

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001225208-24-009655, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 5, 2024SOpen-market sale
Common Stock10b5-1
-25,000$65.91$1.6M198,526Nov 5, 2024

Related signals

Other insiders at Edwards Lifesciences Corp and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
7Weaksell 510b5-1EW
Edwards Lifesciences Corp
Lippis Daniel J.
CVP, JAPAC
$185k2,500
10Weaksell 510b5-1EW
Edwards Lifesciences Corp
BOBO DONALD E JR
CVP,Strategy/Corp Development
$359k5,000
34Weaksell 510b5-1EW
Edwards Lifesciences Corp
Ullem Scott B.
CVP, Chief Financial Officer
$806k11,250
41Moderatesell 5EW
Edwards Lifesciences Corp
Chopra Daveen
CVP, TMTT
$128k1,750
36Weaksell 5EW
Edwards Lifesciences Corp
Markowitz Wayne
GM & SVP, Surgical
$43k583
3Weaksell 210b5-1EW
Edwards Lifesciences Corp
BOBO DONALD E JR
CVP,Strategy/Corp Development
$328k5,000
0Weaksell10b5-1EW
Edwards Lifesciences Corp
BOBO DONALD E JR
CVP,Strategy/Corp Development
$348k5,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.